NCT06834685View on ClinicalTrials.gov

Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

May 31, 2028

Study Completion Date

December 31, 2028

Conditions
Cancer SurvivorsPeripheral Neuropathic Pain
Interventions
DEVICE

Photobiomodulation sessions

The treatment will be administered by an ATP38 device delivering a power of 4 Joules/cm2 at wavelengths of 620 and 820 nm

Trial Locations (1)

34298

RECRUITING

ICM, Montpellier

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT06834685 - Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients | Biotech Hunter | Biotech Hunter